RT Journal Article SR Electronic T1 High Throughput Screening at the Membrane Interface Reveals New Inhibitors of Amyloid-β JF bioRxiv FD Cold Spring Harbor Laboratory SP 853499 DO 10.1101/853499 A1 Sarah J. Cox A1 Brian Lam A1 Ajay Prasad A1 Hannah A. Marietta A1 Nicholas V. Stander A1 Joseph G. Joel A1 Bikash R. Sahoo A1 Fucheng Guo A1 Andrea K. Stoddard A1 Magdalena I. Ivanova A1 Ayyalusamy Ramamoorthy YR 2019 UL http://biorxiv.org/content/early/2019/11/24/853499.abstract AB Amyloid-β aggregation at the cell-membrane of neruonal cells is implicated as a source of toxicity for Alzheimer’s disease. Small molecules have been studied for their ability to supress amyloid aggregation and toxicity, but the presence of membranes negate their activity. Here, we have identified 5 small molecules that are active at the membrane interface.